United States v. Thomas Narog

372 F.3d 1243, 2004 U.S. App. LEXIS 11467, 2004 WL 1299872
CourtCourt of Appeals for the Eleventh Circuit
DecidedJune 10, 2004
Docket02-13437
StatusPublished
Cited by52 cases

This text of 372 F.3d 1243 (United States v. Thomas Narog) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Thomas Narog, 372 F.3d 1243, 2004 U.S. App. LEXIS 11467, 2004 WL 1299872 (11th Cir. 2004).

Opinion

FAY, Circuit Judge:

Appellants Thomas Narog, Mohammed Samhan, Nizar Fneiche and Raed Naser Aldin were convicted by a jury for a variety of offenses involving the possession and distribution of pseudoephedrine, a List One chemical. Among their challenges to their respective convictions, all appellants contend that the trial judge erred when, in response to a query from the jury, the district court responded that the government need only prove that defendants knew or reasonably believed that the pseu-doephedrine would be used to produce any controlled substance. Appellants urge that, because the indictment charged specifically that each participated in the scheme knowing or having reasonable cause to believe that the chemical would be used to manufacture methamphetamine, the district court’s response to the jury’s question constructively amended the indictment. We agree and reverse appellants’ convictions.

I.

In May 1999, Thomas Narog filed an application with the DEA for a license to operate as a wholesale distributor of List One chemicals, including pseudoephedrine. After acquiring his license in July of that year, Narog began doing business as Seaside Pharmaceuticals Corporation and operated out of Shurgard Storage Facility units in Fort Lauderdale, Florida. Beginning in September 1999, Narog received several large shipments containing millions of pseudoephedrine pills, prompting a DEA investigation in March of the following year.

DEA learned that Narog employed the services of defendants Raed Naser Aldin and Mohammed Samhan in loading and *1245 unloading pallets of pseudoephedrine from one storage unit to another. Keeping close tabs on Samhan and Aldin, DEA discovered that a townhouse in Boynton Beach, Florida was involved in the processing of the pills. In June 2000, DEA observed Aldin discarding over 50 trash bags in dumpsters throughout the area surrounding the Boynton townhome. These bags contained empty pseudoephed-rine bottles that were traced to a May shipment to Seaside. Surveillance of the townhouse followed, and on June 4, 2000, agents observed an individual picking up boxes containing 130 pounds of loose pills, which were later received at an “extraction lab” in California. Aldin was again spotted dumping trash bags containing thousands of empty pill bottles in nearby dumpsters, this time accompanied by co-defendant Nizar Fneiche.

DEA eventually suspected that appellants were becoming wise to its surveillance, as Aldin and Samhan were observed on various occasions driving slowly around the storage facility and the townhouse, apparently conducting countersurveillance. During one such outing, when DEA felt that its own surveillance was seriously compromised, agents pulled over Aldin’s car and another following behind, in which Fneiche was a passenger. After being advised of their rights, both agreed to speak. Fneiche gave inconsistent statements as to whether he had been at the townhouse, and Aldin denied it though two bottles of pseudoephedrine were found in his car. Shortly after this traffic stop, the agents acquired a warrant to search the townhouse.

In the townhouse, agents immediately noted that, though large, it was sparsely furnished and apparently not used as a residence. Scattered around several rooms were numerous boxes of pseu-doephedrine, thousands of empty bottles, plastic baggies, cutting utensils and tape. After the search, Fneiche admitted that he had been in the apartment cutting open bottles of pills. DEA seized the evidence, but activity continued at the Shurgard storage units. On June 14, Narog was observed repositioning pallets of pseu-doephedrine between two units, and on June 15, a commercial cargo truck picked up several pallets and delivered them to a nearby Pakmail facility. Samhan and co-defendant Rabah El Haddad were at the Pakmail facility when the truck arrived, and both proceeded to explain to the owner that the pseudoephedrine boxes they were shipping to Oregon contained shoes. DEA agents ultimately seized this and other shipments in Oregon, along with similar shipments to clandestine methamphetamine labs in California.

In the meantime, Narog applied to DEA for an exporter’s license — supposedly to ship pseudoephedrine to JAM and Drug Store, Inc., two pharmaceutical companies in Israel. During the application process, to DEA’s surprise, Narog claimed that he had already exported to Israel all of the pseudoephedrine he had received. He later stated to a DEA investigator that, since applying for his exporter’s license, he had only shipped pills to Impact, a pharmaceutical company in Massachusetts. When questioned about the seizure at the Boynton townhouse, Narog suggested that it might have been stolen from his shipment to Impact. Further investigation by DEA, however, revealed that Narog never had any dealings with Impact, and the Israeli pharmaceutical companies did not exist.

Samhan was arrested on July 29, and DEA found in his South Florida home *1246 thousands of loose pseudoephedrine pills in ziploc bags and boxes bearing Seaside labels. Search warrants were executed at Narog’s residence and Shurgard on the same day. Blank Impact purchase orders were found along with financial records corroborating Seaside’s purchase of pseu-doephedrine in bulk, but no record of legitimate distribution or exportation of the pills was found. Soon after, appellants were indicted for their involvement in the pseudoephedrine distribution scheme.

The original charging document was superseded on February 27, 2001 by a fourteen-count superseding indictment charging appellants Narog, Aldin, Sam-han, Fneiche and other named co-defendants with offenses involving the possession and distribution of pseudoephedrine. Specifically, Count 1 charged appellants with conspiracy to possess and distribute pseudoephedrine “knowing and having reasonable cause to believe that the listed chemical would be used to manufacture a controlled substance, that is, methamphetamine,” in violation of 21 U.S.C. § 846. Count 2 charged appellants Na-rog and Samhan, and co-defendant El Haddad, with conspiracy to manufacture at least 50 grams of methamphetamine, in violation of 21 U.S.C. §§ 846 and 841(a)(1). Counts 3, 6, 8, 10 and 13 charged Narog individually with knowingly and intentionally possessing and distributing pseudoephedrine, again having reasonable cause to believe that it would be used to manufacture a controlled substance, “that is, methamphetamine,” in violation of 21 U.S.C. § 841(d)(2) and 18 U.S.C. § 2. Likewise, Counts 4, 5, 7 and 9 charged Narog with possessing pseu-doephedrine on various dates with intent to manufacture a controlled substance, “that is, methamphetamine,” in violation of 21 U.S.C. 841 § (d)(1) and 18 U.S.C. § 2.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Matthew Zayas
141 F.4th 1217 (Eleventh Circuit, 2025)
United States v. Raquan Emahl Gray
94 F.4th 1267 (Eleventh Circuit, 2024)
Andre v. United States
S.D. Florida, 2022
United States v. Andrew E. Fisher
Eleventh Circuit, 2022
Thomas v. United States
M.D. Florida, 2021
United States v. Laneesha Colston
4 F.4th 1179 (Eleventh Circuit, 2021)
United States v. Pedro Dino Cedado Nunez
1 F.4th 976 (Eleventh Circuit, 2021)
United States v. Jeremy P. Achey
943 F.3d 909 (Eleventh Circuit, 2019)
United States v. James Maarvin Hawkins
934 F.3d 1251 (Eleventh Circuit, 2019)
United States v. Fayez Abu-Aish
Eleventh Circuit, 2018
United States v. Ronen Nahmani
696 F. App'x 457 (Eleventh Circuit, 2017)
United States v. Frederick Jenkins
701 F. App'x 897 (Eleventh Circuit, 2017)
United States v. Richard Altomare
673 F. App'x 956 (Eleventh Circuit, 2016)
United States v. Joseph Castronuovo, M.D.
649 F. App'x 904 (Eleventh Circuit, 2016)
United States v. Nael Sammour
816 F.3d 1328 (Eleventh Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
372 F.3d 1243, 2004 U.S. App. LEXIS 11467, 2004 WL 1299872, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-thomas-narog-ca11-2004.